Keywords: EMA, Europe, Takeda, GlaxoSmithKline, Pfizer, Actos, Pamdemrix, Champix

European Medicines Agency updates on pioglitazone, Pandemrix and Champix

Article | 22 July 2011

Print This

Yesterday saw a batch of recommendations from the European Medicines Agency’s advisory body, including on: Takeda’s ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in